Cresen Solutions LLC was founded in 2015 and is headquartered in the USA. The company was established by life sciences industry veterans with operational and technical experience from organisations including Merck, Stryker, Takeda, and Shire, with a founding mission to deliver improved business outcomes for pharmaceutical and medical device companies through advanced technology and analytical expertise in the compliance domain.

The company operates exclusively within the life sciences vertical, providing project-based technology solutions, custom product development, and consulting services across global compliance, transparency data capture and reporting, healthcare professional (HCP) engagement management, risk assessment and monitoring, and communications compliance. Its solutions incorporate natural language processing (NLP), machine learning (ML), and AI capabilities, and the company has been recognised by Gartner for its innovative approach within the life sciences compliance technology space. Cresen Solutions has presented at the Pharmaceutical Compliance Congress and counts a team of 11–50 employees.

Key Products and Services

HCP Engagement Management

• Software to plan, capture, review, approve, execute, and close out engagements with healthcare professionals and healthcare organisations, including contract and payment workflow management and HCP portal access
• End-to-end HCP engagement lifecycle management from speaker bureau administration through to payment processing and documentation

Global Transparency Reporting

• Tooling to integrate source systems, validate spend data, generate statutory transparency reports for US federal and state Open Payments requirements and EFPIA/local European transparency standards
• Submission-ready file generation with dashboards for spend monitoring and reporting status tracking
• Data warehousing, data integration, and business intelligence solutions supporting transparency data management

Global Risk Assessment and Monitoring

• System to perform risk assessments, schedule and track monitoring activities, capture remediation steps, and deliver role-based dashboards supporting global auditing and monitoring programmes
• Risk-based compliance monitoring across HCP interactions, commercial activities, and business operations

Communications Compliance Monitoring

• Platform that stores commercial communications, applies NLP and ML to flag potential policy violations, supports remediation workflows, and provides reporting and predictive insights
• AI-enabled monitoring of field force, digital, and internal communications for compliance risk identification

Compliance Analytics and AI

• Open Payment Analytics — HCP and healthcare organisation data analytics for spend transparency and compliance intelligence
• Custom AI and machine learning solutions for life sciences compliance use cases, including predictive risk modelling and policy violation detection
• Business intelligence and reporting infrastructure for compliance programme oversight

Consulting Services

• Life sciences compliance consulting encompassing programme design, regulatory interpretation, vendor assessment, and implementation support
• Project-based engagements and custom product development tailored to client-specific compliance architecture requirements

Industry Positioning

Cresen Solutions occupies a focused position within the life sciences commercial compliance technology market, targeting pharmaceutical and medical device companies that require integrated technology solutions for the interconnected compliance obligations of HCP engagement management, transparency reporting, and commercial monitoring. The convergence of these three requirements — driven by US Open Payments, EU EFPIA transparency standards, and tightening enforcement of commercial compliance programmes globally — creates a sustained demand for specialist technology platforms that can manage data across all three domains within a single architecture. Cresen’s differentiation rests on its combination of life sciences domain specificity, AI-augmented monitoring capability, and the practical industry experience of a founding team drawn from major pharmaceutical and device companies, which provides a contextual understanding of enterprise compliance operations that general-purpose compliance software vendors typically lack. With Gartner recognition and active presence at the Pharmaceutical Compliance Congress, the company has established credibility within the compliance technology buyer community.